Data as of Nov 21
| -0.15 / -0.72%|
The 7 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 37.00, with a high estimate of 42.00 and a low estimate of 32.00. The median estimate represents a +79.00% increase from the last price of 20.67.
The current consensus among 7 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.